DE60334536D1 - Furylverbindungen - Google Patents
FurylverbindungenInfo
- Publication number
- DE60334536D1 DE60334536D1 DE60334536T DE60334536T DE60334536D1 DE 60334536 D1 DE60334536 D1 DE 60334536D1 DE 60334536 T DE60334536 T DE 60334536T DE 60334536 T DE60334536 T DE 60334536T DE 60334536 D1 DE60334536 D1 DE 60334536D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- furylverbindungen
- compositions
- therapy
- pharmaceutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201186A SE0201186D0 (sv) | 2002-04-18 | 2002-04-18 | Furyl compounds |
SE0203607A SE0203607D0 (sv) | 2002-12-04 | 2002-12-04 | Furyl compounds |
PCT/SE2003/000613 WO2003087102A1 (en) | 2002-04-18 | 2003-04-15 | Furyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60334536D1 true DE60334536D1 (de) | 2010-11-25 |
Family
ID=29253788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60334536T Expired - Lifetime DE60334536D1 (de) | 2002-04-18 | 2003-04-15 | Furylverbindungen |
Country Status (16)
Country | Link |
---|---|
US (1) | US7417049B2 (de) |
EP (1) | EP1499618B1 (de) |
JP (1) | JP4511195B2 (de) |
KR (1) | KR20040099447A (de) |
CN (1) | CN1325500C (de) |
AT (1) | ATE484508T1 (de) |
AU (1) | AU2003225456B2 (de) |
BR (1) | BR0309343A (de) |
CA (1) | CA2482311C (de) |
DE (1) | DE60334536D1 (de) |
HK (1) | HK1079519A1 (de) |
IL (1) | IL164509A0 (de) |
MX (1) | MXPA04010191A (de) |
NO (1) | NO20044996L (de) |
NZ (1) | NZ561794A (de) |
WO (1) | WO2003087102A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
PL369895A1 (en) | 2001-10-02 | 2005-05-02 | Pharmacia & Upjohn Company | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
US7186836B2 (en) * | 2002-04-18 | 2007-03-06 | Astrazeneca Ab | Thienyl compounds |
CN100494202C (zh) * | 2003-10-21 | 2009-06-03 | 阿斯利康(瑞典)有限公司 | 螺呋喃并吡啶芳基衍生物 |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
EA201001889A1 (ru) | 2008-06-20 | 2011-08-30 | Астразенека Аб | Производные дибензотиазепина и их применение |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
AU2011256287B2 (en) | 2010-05-17 | 2016-11-10 | Envivo Pharmaceuticals, Inc. | A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
WO2011149862A1 (en) * | 2010-05-27 | 2011-12-01 | Targacept, Inc. | Nicotinic receptor non-competitive antagonists modulators |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
US9593106B2 (en) | 2013-02-07 | 2017-03-14 | Heptares Therapeutics Limited | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists |
CA2914263C (en) | 2013-06-21 | 2021-05-18 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
WO2016073407A1 (en) * | 2014-11-04 | 2016-05-12 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
CN108018049B (zh) * | 2016-10-28 | 2019-09-27 | 西安近代化学研究所 | 具有5,6-二氟取代苯并呋喃环的液晶化合物 |
CN108003895B (zh) * | 2016-10-28 | 2019-04-19 | 西安近代化学研究所 | 一种向列相液晶组合物及其显示元件 |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
CA3098151C (en) | 2018-05-10 | 2023-08-22 | Zoetis Services Llc | Endoparasitic depsipeptides |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
DK1397366T3 (da) * | 2001-06-01 | 2007-05-07 | Astrazeneca Ab | Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi |
US7186836B2 (en) * | 2002-04-18 | 2007-03-06 | Astrazeneca Ab | Thienyl compounds |
-
2003
- 2003-04-15 EP EP03746523A patent/EP1499618B1/de not_active Expired - Lifetime
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Application Discontinuation
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en active Application Filing
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
-
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown
-
2005
- 2005-12-14 HK HK05111483A patent/HK1079519A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003087102A1 (en) | 2003-10-23 |
HK1079519A1 (en) | 2006-04-07 |
ATE484508T1 (de) | 2010-10-15 |
JP4511195B2 (ja) | 2010-07-28 |
US20050176745A1 (en) | 2005-08-11 |
NZ561794A (en) | 2008-11-28 |
IL164509A0 (en) | 2005-12-18 |
AU2003225456B2 (en) | 2009-02-05 |
CA2482311A1 (en) | 2003-10-23 |
MXPA04010191A (es) | 2005-02-03 |
EP1499618A1 (de) | 2005-01-26 |
BR0309343A (pt) | 2005-02-15 |
CA2482311C (en) | 2009-12-08 |
JP2005533012A (ja) | 2005-11-04 |
US7417049B2 (en) | 2008-08-26 |
CN1662541A (zh) | 2005-08-31 |
CN1325500C (zh) | 2007-07-11 |
AU2003225456A1 (en) | 2003-10-27 |
EP1499618B1 (de) | 2010-10-13 |
NO20044996L (no) | 2005-01-18 |
KR20040099447A (ko) | 2004-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60334536D1 (de) | Furylverbindungen | |
NO20044995L (no) | Heterosykliske forbindelser | |
HK1079522A1 (en) | Thienyl compounds | |
SE0202463D0 (sv) | Novel compounds | |
IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
SE0401971D0 (sv) | Piperidne derivatives | |
SE0101387D0 (sv) | Novel compounds | |
MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
CY1110498T1 (el) | Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα | |
SE0401970D0 (sv) | Novel compounds | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
SE0302546D0 (sv) | New compounds | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0203303D0 (sv) | Novel Compounds | |
SE0203300D0 (sv) | Novel Compounds | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
SE0203302D0 (sv) | Novel Compounds | |
DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
NO20030500D0 (no) | Dihydroporfyrinderivater og deres anvendelse | |
MXPA06004299A (es) | Derivados de arilespirofuropiridina. | |
DK1638948T3 (da) | Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere | |
ATE416162T1 (de) | Naphthamidderivate und deren verwendung | |
SE0203301D0 (sv) | Novel Compounds |